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Hypothermia Identifies Dynamin as a Potential
Therapeutic Target in Experimental Stroke
Jong Youl Kim, PhD,1,2 Nuri Kim, BS,1 Jong Eun Lee, PhD,2,3 and Midori A. Yenari, MD1
Apoptosis is a cell death pathway that is activated in ischemic stroke. The interaction between Fas and its ligand
(FasL) initiates a complex pattern of intracellular events involving the recruitment of specific adaptor proteins
and the development of apoptosis. We recently reported that dynamin is increased after experimental stroke, and
its inhibition improves neurological outcome. Dynamin has been shown to transport Fas from the endoplasmic
reticulum to the cell surface where it can be bound by its ligand, FasL. Hypothermia has been shown to improve
outcome in numerous stroke models, and this protection is associated with reduced apoptosis and Fas expression.
To explore the contribution of dynamin to hypothermic neuroprotection, we subjected mice to distal middle
cerebral artery occlusion (dMCAO) and applied one of two cooling paradigms: one where cooling began at the
onset of dMCAO (early hypothermia) and another where cooling began 1 hour later (delayed hypothermia),
compared with normothermia (Norm). Both cooling paradigms reduced numbers of apoptotic cells, as well as
Fas and dynamin compared with Norm. Fas and dynamin were co-expressed in neurons. Neuronal cultures were
exposed to oxygen glucose deprivation. Hypothermia decreased dynamin as well as surface expression of Fas,
and this correlated to reduced cell death. The results of this study suggest that dynamin may participate in the
Fas-mediated apoptotic pathway, and its reduction may be linked to hypothermic neuroprotection.
Keywords: hypothermia, ischemic stroke, apoptosis, dynamin, Fas
Introduction
Apoptosis has long been recognized to contribute tobrain cell death after stroke in experimental models
(Ferrer and Planas, 2003). There are two main apoptotic
pathways: the intrinsic pathway, which occurs within the cell’s
mitochondria (Green and Reed, 1998), and the extrinsic path-
way, which is triggered via a cell surface receptor (Ashkenazi
and Dixit, 1998). Although much of the focus on apoptosis in
experimental stroke has centered around the intrinsic or mito-
chondrial pathway, it is also recognized that the extrinsic or
receptor-mediated cell death occurs as well. The most well
known of these receptors is Fas (also referred to as CD95 or
APO-1). The binding of Fas to its extracellular ligand (FasL)
begins the formation of a so-called ‘‘death complex.’’ This
binding leads to the recruitment of Fas-associated death do-
main (FADD) protein and its cytoplasmic adaptor protein
(Lavrik and Krammer, 2012) along with procaspase-8
(Love, 2003). This FasL-Fas-FADD-procaspase-8 complex
is often referred to as a death-inducing signaling complex
(DISC) that, ultimately, leads to the generation of acti-
vated caspase-8 and apoptosis via effector caspases such
as caspase-3. The Fas pathway has been shown to par-
ticipate in several experimental models of neurological
conditions, including ischemic stroke, traumatic brain in-
jury, neuroinflammation, and neurodegeneration (Padosch
et al., 2003).
Dynamin is a guanine triphosphatase that is responsible
for endocytic functions (Ferguson and De Camilli, 2012).
Dynamin-1 is expressed exclusively in neuronal cells of the
brain (Li et al., 2015). Accumulated evidence in several
laboratories demonstrated that dynamin has been impli-
cated in numerous membrane trafficking events, including
phagocytosis (Gold et al., 1999), trafficking to and from
late endosomes and trans-Golgi membranes ( Jones et al.,
1998), and endocytosis-mediated pathogen entry into human
cells (Meier and Greber, 2004). Dynamin has recently
been shown to translocate Fas protein from the Golgi appa-
ratus to the cell surface where it can be bound by FasL
(Ivanov et al., 2006). However, dynamin has not been studied
extensively in the brain, and it has been studied even less in
brain ischemia.
Hypothermia has long been recognized as a potent neuro-
protectant. Experimental studies (Krieger and Yenari, 2004)
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and clinical trials (Bernard et al., 2002) have shown that hy-
pothermia protects the brain from ischemia. Hypothermia has
been shown to slow metabolism, prevent loss of cellular en-
ergy stores, and inhibit release of excitotoxins, including
glutamate. However, these mechanisms do not fully account
for this robust protective effect, as even small decreases in
temperature lead to similar brain protection. Thus, other
processes may contribute to this phenomenon. Several labs,
including ours, have reported that early hypothermia reduces
infarct size and markedly improves neurological recovery
after experimental stroke. Protection by hypothermia is not
only associated with the inhibition of apoptosis via the in-
trinsic or mitochondria-dependent pathway (Inamasu et al.,
2000; Xu et al., 2002) but also appears to decrease apoptosis
via the extrinsic or receptor-mediated pathways (Liu et al.,
2008). We previously showed that therapeutic hypothermia
was associated with the inhibition of FasL cleavage, as levels
of soluble FasL were decreased by cooling (Liu et al., 2008).
Decreased soluble FasL presumably inhibits Fas ligation and,
in turn, reduces caspase-8 activation (Liu et al., 2008).
We recently identified dynamin as a profoundly sup-
pressed protein in HSP70-overexpressing mice subjected to
experimental stroke. Further, HSP70 is known to protect the
brain from stroke, and the inhibition of dynamin does the
same (Kim et al., 2016). Since hypothermia has been viewed
as a ‘‘gold standard’’ of neuroprotection, we explored whe-
ther dynamin suppression may be similarly linked to neuro-
protection by hypothermia. We employ a paradigm identical
to that used in our previously published report where hypo-
thermia led to improved neurological deficits and smaller
infarct size (Kawabori et al., 2013) as a model of hypother-
mic neuroprotection.
Materials and Methods
All experimental manipulations in mice were in accor-
dance to protocols approved by the San Francisco VA
Medical Center’s Institutional Animal Care and Use Com-
mittee (IACUC), and they were within NIH guidelines.
Stroke model
Male C57/B6 mice (Simonson Labs), weighing 20–25 g
and 8–12 weeks old, were anesthetized with isoflurane (5%
for induction, 2% for maintenance via facemask) in an air/
oxygen mixture (3:1) and subjected to permanent distal
middle cerebral artery occlusion (dMCAO) as previously
described with slight modifications (Kawabori et al., 2013).
A small craniotomywas made above the proximal segment of
the middle cerebral artery (MCA), and theMCAwas exposed
after the dura was opened and retracted. The MCA was oc-
cluded by coagulation with a bipolar forceps at the MCA
segment just proximal to the olfactory branch, which was
consistently present. The duration of anesthesia was the same
in all experimental groups. At the time of recovery from
anesthesia, animals were assessed for neurological deficits by
using a Bederson score (Zheng et al., 2008). Those with a
score of 0 or no deficit were removed from the experiment.
Animals were euthanized at 1, 3, and 7 days after ischemia;
brains were prepared for subsequent studies by transcardial
perfusion with normal saline, followed by cryoprotection in
20% sucrose and fixation in 4% paraformaldehyde.
Hypothermia paradigms
Mice were randomized into three groups: early hypothermia
(eHypo), delayed hypothermia (dHypo), and normothermia
(Norm). Cooling to a rectal temperature of 29.5–30.5C was
achieved within 5 minutes of turning off the heating blanket
and spraying the body with 70% alcohol. Rewarming was
achievedwithin 5–10minutes by turning on the heating blanket
and placing a lamp over the animal (Tang et al., 2013). In
the eHypo group, cooling began at the time of dMCAO;
whereas in the dHypo group, cooling began 1 hour after
dMCAO. In both paradigms, cooling was maintained for
2 hours. In the Norm group, rectal temperature was main-
tained in the normal range (36.5–37.5C) throughout the
experiment. We previously showed that rectal tempera-
tures of 37C and 30C corresponded to brain temperatures
of 38C and 33C, respectively (Yenari et al., 2000; Tang
et al., 2013).
Assessing in situ detection of cells with fragmented
DNA (TUNEL stain)
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) using the ApopTag Plus Peroxidase
In Situ Apoptosis Detection Kit (Chemicon) was performed
as previously described by our group (Kim et al., 2014).
Briefly, cryosections in the coronal plane were incubated in
terminal deoxynucleotidyl transferase (TdT) enzyme and
digoxigenin-labeled dUTP at 37C for 1 hour, followed by
reacting with 3,3¢-diaminobenzidine (DAB) substrate. Sec-
tions were counterstained with cresyl violet (CV). Negative
control sections were stained in the same way, but with TdT
eliminated, whereas the lactating mammary gland was used
as a positive control. TUNEL-positive cells were counted
from five random nonoverlapping fields within the cortex
adjacent to the outer boundary of the infarct. The number of
TUNEL-positive cells was expressed as the percentage of
total cells counted from comparable anatomic brain regions
of sham animals.
Immunohistochemistry and immunofluorescence
Brain sections were immunostained for dynamin and Fas.
Cryosections were incubated sequentially in 0.1% hydrogen
peroxidase (3 minutes), 2.5% goat serum blocking buffer
(Vector Laboratories) for 30 minutes, and mouse anti-
dynamin-1 (1:1000; Santa Cruz) or rabbit anti-Fas (1:100;
Santa Curz) antibodies overnight at 4C. Immunoreactivity
was amplified and detected with biotinylated anti-mouse IgG
(1:1000; Vector Laboratories) or anti-rabbit IgG (1:200;
Sigma), peroxidase-conjugated avidin (ABC Elite, Vector
Laboratories), and DAB substrate. Sections were counter-
stained with CV. Colabeling for dynamin and Fas was per-
formed by dual-fluorescence immunostaining. After blocking
in normal serum for 30minutes, brain sectionswere incubated in
antibodies against dynamin and Fas diluted in blocking solution
overnight at 4C. After three washes with phosphate buffered
saline (PBS), sections were incubated with Alexa Fluor 488-
conjugated goat anti-rabbit IgG (1:200; Invitrogen) and Alexa
Fluor 588-conjugated goat anti-mouse IgG (1:1000; Invitro-
gen) for 2 hours at room temperature. After three washes in
PBS, sections were mounted and coverslipped.
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In vitro model of ischemia-like injury
The immortalized mouse neuron cell line, Neuro2A, was
purchased from the American Type Culture Collection. Cul-
tures were grown andmaintained in Dulbecco’s modified eagle
medium (Cellgro) supplementedwith 10%Fetal Bovine Serum
Defined (Hyclone) and antibiotics penicillin and streptomycin
at 100U/mL (Gibco). Under a humidified 5%, CO2 95% air
atmosphere and at 37C, cells were plated in 25 cm2 cell
culture flasks (Corning). Media were changed 2–3 days after
seeding, and flasks were split twice a week. For experiments,
cells were plated on 12-well dishes (1 · 106 cells/well).
Cells were exposed to ischemia-like injury by subjecting
them to oxygen glucose deprivation (OGD) as previously
described (Kim et al., 2015). Cultures were incubated inside
an anoxia chamber for 2 hours at 37C (33C for cultures in
the hypothermia group), and oxygen tension was maintained
at <0.001% (Coy Laboratories). Media were removed and
cultures were washed three times with balanced salt solution
(BSS0) lacking serum, glucose, and oxygen. Control cultures
were incubated at similar temperatures (humidified, 5%CO2)
in BSS containing 5.5mM glucose (BSS5.5) at normoxia.
After 2 hours of OGD, glucose was added to each well to a
final concentration of 5.5mM, and plates were incubated at
normoxia for 24 hours at 5% CO2, at 37C (33C for hypo-
thermia groups).
Cell death and viability were assessed by morphological
assessment by light microscopy, vital staining (trypan blue;
Sigma), and the tetrazolium dye MTT 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) assay.
Immunoblotting
Neuro2A cells were homogenized and solubilized in
radioimmunoprecipitation assay (RIPA) lysis buffer with
protease inhibitor mixture (Complete; ROCHE Applied
Science). Twenty-microgram aliquots of proteins were sub-
jected to sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis, transferred to polyvinylidinene fluoride mem-
branes (Millipore), and probed with mouse anti-dynamin-1
(1:1000; Santa Cruz) followed by corresponding horse-
radish peroxidase (HRP)-conjugated secondary antibodies
(1:1000; Bio-Rad). Blots were visualized by using the ECL
system (Amersham) according to the manufacturer’s in-
structions, and they were imaged by using ChemiDoc (Bio-
Rad). Equal protein loading was confirmed by re-probing
actin, which was used as a housekeeping protein.
Flow cytometry
After OGD, 1· 106 N2a cells were washed once in PBS and
blocked with Flow Cytometry Staining Buffer (eBioscience)
for 10minutes. Nonpermeabilized cells were then stained with
mouse anti-Fas (1:1000; Santa Cruz) antibody for 1 hour, Alexa
Fluor 488-conjugated goat anti-mouse IgG (1:1000; Invitro-
gen) for 20 minutes and normal mouse IgG-PE (Santa Cruz)
was used as an isotype control for 10 minutes at 4C in dark-
ness. N2a cells were sorted on FACSCalibur (BDBiosciences),
and data were analyzed by using CellQuest (BD Biosciences).
Statistical analysis and rigor
For in vivo studies, animals were assigned to experimental
groups in a randomized fashion. For in vitro studies, a given
run was carried out at the same temperature for a given day,
since the anoxia chamber and incubator had to be re-adjusted
to the different temperatures. However, experiments were
carried out in triplicate from different aliquots of cells, and
they were repeated three times on different days. All data
analysis was performed by investigators who were blinded to
the experimental conditions.
All data were analyzed with standard statistical methods
(T-test for two groups and analysis of variance (ANOVA) for
more than two groups; Systat Software, Inc., San Jose, CA).
p Values ofp0.05 were considered significant. Quantitative
data are presented as the mean – standard error.
Results
A total of 103 mice were subjected to dMCAO; none were
excluded from the analysis as all animals had an obvious
deficit at the time of recovery from anesthesia and had a
visible ischemic lesion on histology. Four of the animals died
prematurely, with three in the Norm group and one in the
dHypo group.
FIG. 1. Hypothermia reduces numbers of TUNEL-
positive cells 3 days after experimental stroke. (a) Under
conditions of normothermia (Norm), increased numbers of
TUNEL-positive cells are present in the ischemic cortex.
These numbers are reduced when compared with when
cooling was delayed for 1 hour (dHypo) or instituted im-
mediately after occlusion (eHypo). (b) Graphs of these
counts show TUNEL cells normalized to total cell counts
from sham uninjured sections stained with cresyl violet.
There are fewer TUNEL-positive cells in brains from both
hypothermic groups compared with the Norm group, and
significantly fewer positive cells among the eHypo com-
pared with the dHypo (n = 6/group; *p< 0.01, **p < 0.05,
scale bar= 50lm). TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling.
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Hypothermia decreases TUNEL staining after
ischemic stroke
Brain sections from mice subjected to dMCAO followed
by 3 days of survival were stained with TUNEL to identify
cells with DNA damage, consistent with apoptosis. The
brains from the Norm group had numerous TUNEL-positive
cells in the ischemic cortex compared with the sham group. In
contrast, both hypothermia-treated groups had significantly
reduced numbers of TUNEL-positive cells (Fig. 1).
Hypothermia decreases expression of dynamin-1
and Fas protein after ischemic stroke
Very little dynamin-1 or Fas could be seen in uninjured
sham brains, but both proteins were increased after stroke.
Marked increases in dynamin-1 and Fas were observed at 3
and 7 days. Expression of both proteins in eHypo brains was
lower than that observed in dHypo, but both hypothermic
groups had lower counts compared with the Norm group
(Fig. 2).
To determine whether dynamin-1 and Fas were expressed
in the same cells, we colabeled for both proteins. We found
that, indeed, both proteins colocalized to neuron-like cells
and were increased in Norm brains compared with eHypo and
dHypo (Fig. 3). Numbers of colabeled cells were lower in the
FIG. 2. (a, b) Dynamin-1
is increased in neuron-like
cells after dMCAO compared
with uninjured shams. One,
3, and 7 days post-dMCAO,
dynamin-1 is increased more
in Norm brains, compared
with the hypothermia groups
(dHypo, eHypo). (c, d) Fas
expression is similarly in-
creased in ischemic brains
compared with uninjured
shams, and Fas staining is
decreased in dHypo and
eHypo brains (n = 7–8/group;
*p < 0.01, **p < 0.001).
FIG. 3. Dynamin-1 and Fas colocalize in neuron-like cells
3 days after experimental stroke. Immunofluorescent stains
of dynamin-1 (red) and fas (green) colocalize in brains of
mice subjected to dMCAO. A merged image (Merge) shows
that many of these cells express both proteins (yellow).
Expression of both Fas and dynamin-1 was reduced in hy-
pothermic brains (dHypo and eHypo) compared with nor-
mothermic brains (Norm) (scale bar= 10lm). dMCAO,
distal middle cerebral artery occlusion.
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hypothermic brains, whereas the pattern of colocalization
did not change.
Hypothermia decreases dynamin-1 and surface
expression of Fas in a cell culture model
of ischemia-like injury
To further explore the mechanism of dynamin in hypo-
thermic protection, we turned to a well-established model of
in vitro ischemia. OGD-exposed N2a cells under hypother-
mic conditions (Hypo) survived better and suffered less cell
death compared with the Norm group (Fig. 4a, b). To better
quantitatively assess dynamin expression, Western blot
analysis showed that OGD increased dynamin-1 expression
nearly twofold compared with uninjured control cultures, and
this was blunted by hypothermia (Fig. 4c, d). Since dynamin
is believed to traffick Fas to the surface where it can be
ligated by FasL, we surface labeled (non-permeabilizing
conditions) N2a cells with antibodies against Fas and esti-
mated the numbers of Fas-positive neurons by flow cytom-
etry. OGD increased numbers of Fas-positive cells, which
was decreased by*38% by Hypo (Fig. 4e, f).
Discussion
We show here that dynamin is upregulated after dMCAO,
and this is associated with increased Fas expression. We
detected both proteins in the same cells, and both were
similarly reduced under conditions of therapeutic hypother-
mia. Because dynamin is believed to traffick Fas to the cell
surface (Ivanov et al., 2006), increased dynamin could con-
ceivably increase apoptosis and neuronal death. We further
show that in an in vitromodel, ischemia-like injury increased
the expression of Fas on the cell surface, which was also
reduced by hypothermia. These observations may indicate
that one mechanism by which hypothermia protects is by
inhibiting dynamin expression and, thus, downregulating Fas
expression on the cell’s surface.
Hypothermia has been shown to inhibit both apoptotic
pathways, but more studies have focused on its effect on the
intrinsic pathway (Yenari and Han, 2012). In models of global
cerebral ischemia, hypothermia has been shown to inhibit
mitochondrial cytochrome c release, a major trigger of the
intrinsic apoptotic pathway, and subsequent caspase activa-
tion. Hypothermia also differentially alters the expression of
FIG. 4. Hypo protects cul-
tured neurons from ischemia-
like insults and similarly
decreases dynamin-1 and
expression of Fas on the cell
surface. Cultures of N2a cells
were subjected to OGD for
2 hours followed by 24 hours
of reperfusion at either nor-
mothermia (Norm, 37C) or
hypothermia (Hypo, 33C).
Cells not exposed to OGD but
placed in similar media con-
taining 5.5mM glucose were
studied in parallel (Cont).
MTT (a) and trypan blue
stains (b) showed increased
cell viability and decreased
cell death, respectively, with
Hypo. Immunoblots of N2a
cells exposed to OGD showed
increases in dynamin-1 ex-
pression, whereas Hypo re-
duced this expression. (c, d)
Quantification of the immu-
noblots shows a significantly
greater reduction of dynamin-
1 by Hypo compared with
Norm. (e, f) Non-
permeabilized N2a cells were
subjected to flow cytometry
after labeling with anti-Fas
antibody. OGD increased
numbers of cells that ex-
pressed Fas on the surface,
and this was decreased by
Hypo (All experiments repre-
sent pooled results from cul-
tures studied in triplicate and
repeated on three separate
days. *p<0.01). Hypo, hypo-
thermia; OGD, oxygen glu-
cose deprivation.
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Bcl-2 family members. The pro-apoptotic family member Bax
decreases with cooling, whereas the anti-apoptotic member
Bcl-2 increases. Hypothermia has been studied less with re-
spect to the extrinsic pathway, but as previously mentioned,
both FasL and caspase-8 are reduced with cooling.
Relevant to neurological disease, dynamin-1 deficiency
has been linked to deficits in c-amino butyric acid transmis-
sion and epilepsy (Ferguson and De Camilli, 2012). Although
mutations in dynamin-2 have been the best characterized in
the inherited neuropathy, Charcot-Marie-Tooth disease, in-
tact dynamin has also been shown to have detrimental results.
Dynamin has also been linked to Alzheimer’s disease pathol-
ogy, where dynamin was shown to influence amyloid gener-
ation through beta-site amyloid precursor protein-cleaving
enzyme-1 (Zhu et al., 2012). Its inhibition or deficiency led to a
reduction in Alzheimer’s pathology and neuronal degeneration
(Cirrito et al., 2008). Recently, a proteomics-based approach
showed that dynamin-1 was upregulated 6 hours poststroke
(Chen et al., 2014). This is consistent with our own observa-
tions of dynamin in our stroke model, and that it can be
downregulated by the neuroprotective chaperone protein
Hsp70 (Kim et al., 2016).
There are scant reports of dynamin in the ischemia litera-
ture, but there are a few reports of dynamin-related protein-1
(Drp1) and its role in mitochondrial fission. In cardiac and
renal ischemia, the inhibition of Drp1 was found to prevent
mitochondrial apoptosis (Brooks et al., 2009). Therapeutic
hypothermia was also shown to suppress Drp1 dephosphor-
ylation and to maintain mitochondrial morphology and
myocardial function (Sharp et al., 2014). There are a few
reports characterizing Drp1 in experimental stroke (Liu et al.,
2012), and Drp1 inhibition also decreased apoptosis (Grohm
et al., 2012). However, the site and the mechanism of action
of Drp-1 and dynamin-1 appear distinct.
The precise relationship between dynamin and hypother-
mia is completely unknown, and to our knowledge, has never
been reported earlier. Considered together, the data presented
here suggest that dynamin contributes negatively to brain cell
survival after ischemia, and it is reduced by hypothermia.
Based on our own experiments and those in related literature,
potential links between dynamin and hypothermia include
the regulation of dynamin at the transcriptional level. For
instance, the promoter region of dynamin contains a sequence
similar to that recognized by nuclear factor kappa B (NF-kB)
(Han et al., 2003). In prior work, our lab showed that hypo-
thermia inhibited the transcriptional activity of NF-kB by
directly binding NF-kB or interfering with its inhibitory ki-
nase (Han et al., 2003). Thus, it is possible that hypothermia
interferes with dynamin at the level of mRNA induction. It is
also possible that hypothermia may directly inhibit dynamin-
dependent Fas translocation by attenuating dynamin-1 in the
cytosol through cooling, thereby preventing the trafficking of
Fas by dynamin. The work presented here is correlative and
does not prove causation. Although our prior study showed
that dynamin inhibition led to improved neurological out-
come in this same stroke model, our data here do not establish
whether dynamin is definitively responsible for the observed
neuroprotection by hypothermia (Kim et al., 2016). Future
studies might address whether hypothermia fails to protect
when dynamin is overexpressed, and functional studies
should clarify whether dynamin is regulated at the transcrip-
tional or post-translational stage in brain ischemia. It also bears
mention that the hypothermia paradigms here are used as a
model of neuroprotection to understand stroke pathophysi-
ology. They do not necessarily translate directly to clinical
scenarios where different circumstances such as longer dura-
tions of cooling may be necessary, and where there are other
challenges regarding the induction of hypothermia.
Conclusion
Our findings here identify a previously unappreciated
correlation between hypothermia and its anti-apoptotic
function via suppression of dynamin. Taken in context with
the current dynamin literature, these results suggest that dy-
namin may be an unappreciated link in the extrinsic apoptotic
pathway in stroke, and they shed light on one possible
mechanism underlying hypothermia-mediated neuroprotec-
tion. This work also suggests that dynamin may be a viable
therapeutic target.
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